Copyright
©The Author(s) 2020.
World J Gastroenterol. Jul 21, 2020; 26(27): 3917-3928
Published online Jul 21, 2020. doi: 10.3748/wjg.v26.i27.3917
Published online Jul 21, 2020. doi: 10.3748/wjg.v26.i27.3917
Table 1 Clinicopathological features of the chronic hepatitis B patients included in this study
| Parameters | Chronic hepatitis B | P value1 | |
| No or mild fibrosis | Advanced fibrosis | ||
| (S0-1, n = 16) | (S3-4, n = 16) | ||
| Gender | 0.716 | ||
| Male | 11 | 9 | |
| Female | 5 | 7 | |
| Age (yr) | 0.479 | ||
| < 45 | 9 | 6 | |
| ≥ 45 | 7 | 10 | |
| ALT (U/L) | 0.704 | ||
| < 50 | 12 | 10 | |
| ≥ 50 | 4 | 6 | |
| HBV-DNA (copies/mL) | 0.479 | ||
| < 105 | 10 | 7 | |
| ≥ 105 | 6 | 9 | |
| Inflammation | 0.037 | ||
| G1-2 | 15 | 9 | |
| G3-4 | 1 | 7 | |
- Citation: Yao QY, Feng YD, Han P, Yang F, Song GQ. Hepatic microenvironment underlies fibrosis in chronic hepatitis B patients. World J Gastroenterol 2020; 26(27): 3917-3928
- URL: https://www.wjgnet.com/1007-9327/full/v26/i27/3917.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i27.3917